Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

Stephanie A. Amiel, Pablo Aschner, Belinda Childs R N, Philip E. Cryer, Bastiaan E. de Galan, Simon R. Heller, Brian M. Frier, Linda Gonder-Frederick, Timothy Jones, Timothy Jones, Kamlesh Khunti, Lawrence A. Leiter, Rory J. McCrimmon, Yingying Luo, Elizabeth R Seaquist, Robert Vigersky, Sophia Zoungas, The International Hypoglycaemia Study Group

Research output: Contribution to journalArticlepeer-review

71 Scopus citations
Original languageEnglish (US)
Pages (from-to)3-6
Number of pages4
Issue number1
StatePublished - Jan 1 2017

Bibliographical note

Funding Information:
The International Hypoglycaemia Study Group (IHSG) is supported through an unrestricted educational grant from Novo Nordisk awarded to Six Degrees Academy (SDA) of Toronto, ON, Canada. Along with the IHSG chair, SDA has been solely responsible for membership recruitment/selection and content/outcomes for the meetings. The rationale for the formation of IHSG is that hypoglycaemia is an under-recognised problem that deserves increased awareness and focus across the healthcare community. The group’s ultimate goal is to improve the lives of patients with diabetes.

Cite this